<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39399302</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2515-1355</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Therapeutic advances in vaccines and immunotherapy</Title><ISOAbbreviation>Ther Adv Vaccines Immunother</ISOAbbreviation></Journal><ArticleTitle>Vaccine skepticism and vaccine development stages; inoculation from "cowpox" lesion to the current mRNA vaccine of COVID-19: review.</ArticleTitle><Pagination><StartPage>25151355241288135</StartPage><MedlinePgn>25151355241288135</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25151355241288135</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/25151355241288135</ELocationID><Abstract><AbstractText>Global pandemics can be tackled by two means: lockdowns and vaccinations. As vaccination has a low impact on economic outcomes and better acceptance by people, it is the preferred method by most governments as a medium- to long-term solution. Vaccines have played a significant role in reducing the global burden of infectious diseases. They are designed to teach the immune system how to fight a particular infection before it causes a disease in subsequent exposures by creating a memory. Although vaccines effectiveness is well known, anti-vaccination movements pose significant challenges, even in high-income settings, leading to outbreaks of life-threatening infectious diseases. Hesitancy to take vaccines is not new and began with the first vaccination of smallpox. At that time, the problem was solved by a regulatory obligation to take vaccines, declared in England and Wales in 1853, which eventually led to its eradication in 1980. Different studies show that there is a decline in awareness of vaccines, hesitancy to take them, and concerns and trust issues regarding healthcare professionals. These problems have been rising over the past few decades for several reasons, notably, because of misinformation spread by social media. Therefore, the objective of this review is to provide a brief overview about vaccine hesitancy and attributable factors, illustrate the different types of vaccines, show the major challenges of vaccine development, and illustrate the pros and cons of each type.</AbstractText><CopyrightInformation>© The Author(s), 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tafere</LastName><ForeName>Chernet</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7792-5704</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, P. O. Box. 79, Bahir Dar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demsie</LastName><ForeName>Desalegn Getnet</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tefera</LastName><ForeName>Bereket Bahiru</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yehualaw</LastName><ForeName>Adane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feyisa</LastName><ForeName>Kebede</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yismaw</LastName><ForeName>Malede Berihun</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yayehrad</LastName><ForeName>Ashagrachew Tewabe</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Vaccines Immunother</MedlineTA><NlmUniqueID>101718382</NlmUniqueID><ISSNLinking>2515-1355</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Hesitancy to take vaccines and stages of vaccine development starting from the first vaccine; inoculation from “cowpox” wound to the current mRNA vaccine of COVID-19: Review Global pandemics can be tackled by two means: lockdowns and vaccinations. As vaccination has a low impact on economic outcomes, it is the preferred method by most governments as a medium- to long-term solution. Vaccines play a significant role in reducing the global burden of infectious diseases. They are designed to teach our body defense mechanism how to fight a particular infection before it causes a disease in subsequent infections by creating a memory. Although its effectiveness is well known, anti-vaccination movements pose many challenges, even in high-income settings, leading to outbreaks of life-threatening infectious diseases. Vaccine hesitancy is not new and began with the first vaccination of smallpox. At that time, the problem was solved by a regulatory obligation to take vaccines, declared in England and Wales in 1853, which eventually led to its eradication in 1980. Different studies show that there is a decline in awareness of vaccines, hesitancy to take them, and concerns and trust issues regarding healthcare professionals. These problems have been rising over the past decades for a number of reasons. Therefore, the objective of this review is to provide a brief overview of the different types of vaccines, show the major challenges of vaccine development, and illustrate the pros and cons of each type.</AbstractText><CopyrightInformation>© The Author(s), 2024.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mRNA vaccine of COVID-19</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">vaccine hesitancy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399302</ArticleId><ArticleId IdType="pmc">PMC11471007</ArticleId><ArticleId IdType="doi">10.1177/25151355241288135</ArticleId><ArticleId IdType="pii">10.1177_25151355241288135</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Czochor J, Turchick A. Introduction. YALE J Biol Med 2014; 87: 401–402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4257027</ArticleId><ArticleId IdType="pubmed">25647837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallusto F, Lanzavecchia A, Araki K, et al.. From vaccines to memory and back. Immunity 2010; 33(4): 451–463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760154</ArticleId><ArticleId IdType="pubmed">21029957</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 2021; 21(2): 83–100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7754704</ArticleId><ArticleId IdType="pubmed">33353987</ArticleId></ArticleIdList></Reference><Reference><Citation>
HHS.gov. Vaccine Types. U.S. Department of Health and Human Services, https://www.hhs.gov/immunization/basics/types/index.html (2021, accessed 05 September 2024).</Citation></Reference><Reference><Citation>Choudhary P, Shafaati M, Salah MAHA, et al.. Zoonotic diseases in a changing climate scenario: revisiting the interplay between environmental variables and infectious disease dynamics. Travel Med Infect Dis 2024; 58: 10–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">38336336</ArticleId></ArticleIdList></Reference><Reference><Citation>Qader DHA, Abdel H, Jennifer Q, et al.. Active safety surveillance of four types of COVID-19 vaccines: a National Study from Jordan. Clin Drug Investig 2022; 42(10): 813–827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9398044</ArticleId><ArticleId IdType="pubmed">35999428</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood B. The contribution of vaccination to global health: past, present and future. Phil Trans R Soc B 2014; 369: 1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024226</ArticleId><ArticleId IdType="pubmed">24821919</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Omer SB. Why and how vaccines work. Cell 2020; 183: 290–295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560117</ArticleId><ArticleId IdType="pubmed">33064982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardi N, Hogan MJ, Porter FW, et al.. mRNA vaccines—a new era in vaccinology. Nat Rev Drug Discov 2018; 17(4): 261–279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5906799</ArticleId><ArticleId IdType="pubmed">29326426</ArticleId></ArticleIdList></Reference><Reference><Citation>
Simonsen K, Snowden J.
Smallpox, https://europepmc.org/article/nbk/nbk470418 (2017, accessed 07 September 2024).</Citation></Reference><Reference><Citation>Stewart AJ, Devlin PM. The history of the smallpox vaccine. J Infect 2006; 52: 329–334.</Citation><ArticleIdList><ArticleId IdType="pubmed">16176833</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubé È, Ward JK, Verger P, et al.. Vaccine hesitancy, acceptance, and anti-vaccination : trends and future prospects for public health. Annu Rev Public Heal 2021; 42: 175–191.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798403</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver D, Kim Y, Mcneill E, et al.. Association between COVID-19 vaccine hesitancy and trust in the medical profession and public health officials. Prev Med 2022; 164: 107311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9580241</ArticleId><ArticleId IdType="pubmed">36272515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol 2010; 125(2): S33–S40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20061006</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JS, Warrington R, Watson W, et al.. An introduction to immunology and immunopathology. Allergy, Asthma Clin Immunol 2018; 14(s2): 1–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156898</ArticleId><ArticleId IdType="pubmed">30263032</ArticleId></ArticleIdList></Reference><Reference><Citation>Palm AE, Henry C. Remembrance of things past : long-term B cell memory after infection and vaccination. Front Immunol 2019; 1787: 1–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6685390</ArticleId><ArticleId IdType="pubmed">31417562</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaplin D. Overview of the immune response. J Allergy Clin Immunol 2010; 125(2): S3–S23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2923430</ArticleId><ArticleId IdType="pubmed">20176265</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern PL. Key steps in vaccine development. Ann Allergy Asthma Immunol 2020; 125(1): 17–27.</Citation><ArticleIdList><ArticleId IdType="pubmed">32044451</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoit SL, Mauldin RF. The “ anti-vax” movement : a quantitative report on vaccine beliefs and knowledge across social media. BMC Public Health 2021; 21(1): 1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8596085</ArticleId><ArticleId IdType="pubmed">34789206</ArticleId></ArticleIdList></Reference><Reference><Citation>
King J.
The smallpox vaccine, Edward Jenner and a cow called Blossom, https://artuk.org/discover/stories/the-smallpox-vaccine-edward-jenner-and-a-cow-called-blossom (2020, accessed 26 February 2024).</Citation></Reference><Reference><Citation>Mnookin S. The panic virus: a true story of medicine, science, and fear. New York, NY: Simon and Schuster, 2011.</Citation></Reference><Reference><Citation>Grabenstein JD. What the World’ s religions teach, applied to vaccines and immune globulins. Vaccine 2023; 31(16): 2011–2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">23499565</ArticleId></ArticleIdList></Reference><Reference><Citation>Volet AK, Scavone C, Catalán-matamoros D, et al.. Vaccine hesitancy among religious groups : reasons underlying this phenomenon and communication strategies to rebuild trust. Front Public Health 2022; 10(February): 1–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8858841</ArticleId><ArticleId IdType="pubmed">35198525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hearld KR, Budhwani H. Human papillomavirus (HPV) and influenza vaccine behavior among Muslim women in the United States. Health Care Women Int 2019; 41: 532–542.</Citation><ArticleIdList><ArticleId IdType="pubmed">31194672</ArticleId></ArticleIdList></Reference><Reference><Citation>Trangerud HA. What is the problem with vaccines ?” A typology of religious vaccine skepticism. Vaccine X 2023; 14: 100349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10362305</ArticleId><ArticleId IdType="pubmed">37484867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir S, Aliyu G, Ya I, et al.. From intense rejection to advocacy : how muslim clerics were engaged in a polio eradication initiative in. PLOS Med 2014; 11(8): 1–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4122353</ArticleId><ArticleId IdType="pubmed">25093661</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahya M. Polio vaccines—“no thank you!” barriers to polio eradication in Northern Nigeria. Afr Aff 2007; 106(423): 185–204.</Citation></Reference><Reference><Citation>Ali SA, Suhali N, Hadi H, et al.. Polio—an endemic disease in Pakistan : literature review. i-manager’s J Nurs 2015; 5(1): 29–33.</Citation></Reference><Reference><Citation>Misra B. “ Sitala :” the small-pox goddess of India Sitala : the small-pox goddess of India. JSTOR 1969; 28(2): 133–142.</Citation><ArticleIdList><ArticleId IdType="pubmed">11614234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins DR. Smallpox: ten years gone. Am J Public Health 1988; 78(12): 1589–1595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1349746</ArticleId><ArticleId IdType="pubmed">2461102</ArticleId></ArticleIdList></Reference><Reference><Citation>Behbehani AM. The smallpox story : life and death of an old diseaset. Microbiol Rev Dec 1983; 47(4): 455–509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC281588</ArticleId><ArticleId IdType="pubmed">6319980</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO. Interrater Reliability of Causality Assessment for Serious Adverse Events Following Immunization. https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/aefi/serious-aefi (2018, accessed 08 September 2024).</Citation></Reference><Reference><Citation>Liu D, Wu W, Li K, et al.. Surveillance of adverse events following immunization in China: past, present, and future.Vaccine 2015; 33: 4041–4046.</Citation><ArticleIdList><ArticleId IdType="pubmed">25936727</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VN, An H, Thanh T, et al.. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021. Vaccine 2020; 39: 6485–6491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8485226</ArticleId><ArticleId IdType="pubmed">34607748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen C, Healy K, Tate JE, et al.. Rotavirus vaccination and intussusception – science, surveillance, and safety : a review of evidence and recommendations for future research priorities in low and middle income countries. Hum Vaccin Immunother 2016; 12(10): 2580–2589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5084992</ArticleId><ArticleId IdType="pubmed">27322835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaldo G, Noseda R, Ceschi A, et al.. Evaluation of the safety profile of rotavirus vaccines : a pharmacovigilance analysis on American and European data. Sci Rep 2020; 10(1): 1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423960</ArticleId><ArticleId IdType="pubmed">32788620</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC. Questions &amp; Answers about Intussusception and Rotavirus Vaccine. https://www.cdc.gov/vaccines/vpd/rotavirus/about-intussusception.html#print (2017, accessed 08 September 2024).</Citation></Reference><Reference><Citation>Martino GD, Mazzocca R, Camplone L, et al.. Attitudes and beliefs towards rotavirus vaccination in a sample of Italian women : a cross-sectional study. Vaccines 2023; 11(1041): 3–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10302617</ArticleId><ArticleId IdType="pubmed">37376430</ArticleId></ArticleIdList></Reference><Reference><Citation>Le LKT, Pham TPT, Mai LTP, et al.. Intussusception and other adverse event surveillance after pilot introduction of rotavirus vaccine in Nam Dinh and Thua Thien Hue Provinces—Vietnam, 2017–2021. Vaccines 2024; 12(170): 1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10893515</ArticleId><ArticleId IdType="pubmed">38400153</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett E, Riaz A, Anwari P. Intussusception risk following oral monovalent rotavirus vaccination in 3 Asian countries: a self-control case series evaluation. Vaccine 2024; 41(48): 7220–7225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10929074</ArticleId><ArticleId IdType="pubmed">37884416</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta PL, Caballero MT, Polack FP. Brief history and characterization of enhanced respiratory syncytial virus disease. Clin Vaccine Immunol 2016; 23(3): 189–195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783420</ArticleId><ArticleId IdType="pubmed">26677198</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Alvarez-paggi D, Libster R, et al.. Fatal enhanced respiratory syncytial virus disease in toddlers. Sci Transl Med 2023; 13(616): 1–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10712289</ArticleId><ArticleId IdType="pubmed">34669442</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima K, Syed NI. Dengvaxia controversy: impact on vaccine hesitancy. J Glob Heal 2018; 8(2): 8–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6214489</ArticleId><ArticleId IdType="pubmed">30410732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasco G, Yu VG. Communicating COVID-19 vaccines : lessons from the dengue vaccine controversy in the Philippines. BMJ Glob Heal 2021; 6: 1–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929792</ArticleId><ArticleId IdType="pubmed">33653732</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson HJ, Hartigan-go K, Figueiredo A. De. Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness. Hum Vaccin Immunother 2019; 15(3): 625–627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605722</ArticleId><ArticleId IdType="pubmed">30309284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A, Ali S, Ahmed M, et al.. The anti-vaccination movement: a regression in modern medicine. Cureus 2018; 10(7): 1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6122668</ArticleId><ArticleId IdType="pubmed">30186724</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO. More than 140,000 Die from Measles as Cases Surge Worldwide. https://www.who.int/news-room/detail/05-12-2019-more-than-140-000-die-from-measles-as-cases-surge-worldwide (2019).</Citation></Reference><Reference><Citation>
CDC. Measles can come to the United States from anywhere. https://www.cdc.gov/global-measles-vaccination/data-research/global-measles-outbreaks/index.html (2023, accessed 10 September 2024).</Citation></Reference><Reference><Citation>Bedford H, Donovan H. We need to increase MMR vaccine uptake urgently. BMJ 2022; 1–2.</Citation><ArticleIdList><ArticleId IdType="pubmed">35354576</ArticleId></ArticleIdList></Reference><Reference><Citation>Healy A. Measles: increasing vaccine uptake is vital in preventing outbreaks. BMJ 2024; 384: 1–2.</Citation><ArticleIdList><ArticleId IdType="pubmed">38359945</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine 2015; 33: 4161–4164.</Citation><ArticleIdList><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonhoeffer J, Heininger U. Adverse events following immunization : perception and evidence. Curr Opin Infect Dis 2007; 20: 237–246.</Citation><ArticleIdList><ArticleId IdType="pubmed">17471032</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka Choudhary OP, Singh I. Making sound public health decisions for the roll-out of COVID-19 vaccines. J Travel Med 2021: 1–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989503</ArticleId><ArticleId IdType="pubmed">33690836</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary OP, Choudhary P, Singh I, et al.. India’s COVID-19 vaccination drive: key challenges and resolutions. Lancet Infect Dis 2021; 21: 1483–1484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437681</ArticleId><ArticleId IdType="pubmed">34529961</ArticleId></ArticleIdList></Reference><Reference><Citation>Recio-rom A, Recio-men M, Román-González MV. Influence of media information sources on vaccine uptake : the full and inconsistent mediating role of vaccine hesitancy. Computation 2023; 11(208): 1–20.</Citation></Reference><Reference><Citation>Ngai CSB, Singh RG, Yao L. Impact of COVID-19 vaccine misinformation on social media virality: content analysis of message themes and writing strategies. J Med Internet Res 2022; 24(7): e37806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9301555</ArticleId><ArticleId IdType="pubmed">35731969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Heal 2020; 5(10): e004206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7590343</ArticleId><ArticleId IdType="pubmed">33097547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri K. Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media. BMJ 2024; 384: e076542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10789192</ArticleId><ArticleId IdType="pubmed">38228339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehari EA, Mekonen TG, Adugnaw MT, et al.. Prevalence of COVID-19 vaccine hesitancy and its associated factors among chronic disease patients in a resource limited setting in Ethiopia: a cross-sectional study. Adv Public Heal 2023; 2023: 1–11.</Citation></Reference><Reference><Citation>Ackah BBB, Woo M, Stallwood L, et al.. COVID-19 vaccine hesitancy in Africa: a scoping review. Glob Heal Res Policy 2022; 7(21): 1–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9294808</ArticleId><ArticleId IdType="pubmed">35850783</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmin F, Najeeb H, Moeed A, et al.. COVID-19 vaccine hesitancy in the United States : a systematic review. Front Public Heal 2021; 9: 1–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8650625</ArticleId><ArticleId IdType="pubmed">34888288</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh A, Qamar S, Tekin A, et al.. Vaccine development throughout history. Cureus 2021; 13(7): e16635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386248</ArticleId><ArticleId IdType="pubmed">34462676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain S. Chapter 13 Immunization and vaccination. Psychiatr Pandemic 2019: 153–177.</Citation></Reference><Reference><Citation>Riedel S. Edward Jenner and the history of smallpox and vaccination. BUMC Proc 2005; 18(1): 21–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1200696</ArticleId><ArticleId IdType="pubmed">16200144</ArticleId></ArticleIdList></Reference><Reference><Citation>Berche P. Louis Pasteur, from crystals of life to vaccination. Clin Microbiol Infect 2012; 18 (Suppl 5): 1–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22882766</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Maltezou HC. Travel vaccines throughout history Androula. Travel Med Infect Dis 2022; 46: 102278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8837496</ArticleId><ArticleId IdType="pubmed">35167951</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotkin SA, Plotkin SL. The development of vaccines: how the past led to the future. Nat Rev Microbiol 2011; 9: 889–893.</Citation><ArticleIdList><ArticleId IdType="pubmed">21963800</ArticleId></ArticleIdList></Reference><Reference><Citation>
VBI. Louis Pasteur and the development of the attenuated vaccine. VBI Vaccine Inc. https://www.vbivaccines.com/evlp-platform/louis-pasteur-attenuated-vaccine/ (2023).</Citation></Reference><Reference><Citation>Chavda VP, Bezbaruah R, Athalye M, et al.. Replicating viral vector-based vaccines for COVID-19 : potential avenue in vaccination arena. Viruses 2022; 14(4): 759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9025561</ArticleId><ArticleId IdType="pubmed">35458489</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueckert C, Guzma CA. Vaccines: from empirical development to rational design. PLOS Pathog 2012; 8(11): e1003001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493475</ArticleId><ArticleId IdType="pubmed">23144616</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos E, Levitz SM. Fungal vaccines and immunotherapeutics. Cold Spring Harb Perspect Med 2014; 4(11): a019711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4208708</ArticleId><ArticleId IdType="pubmed">25368016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento IP, Leite LCC. Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res 2012; 45(12): 1102–1111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3854212</ArticleId><ArticleId IdType="pubmed">22948379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahariya C. Vaccine epidemiology : a review. J Fam Med Prim Care 2016; 5(1): 7–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4943153</ArticleId><ArticleId IdType="pubmed">27453836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak TW, Saunders ME JB. Chapter14 – Vaccination. Primer to the immune response. 2nd ed. Switzerland: MDPI, 2014.</Citation></Reference><Reference><Citation>Ghattas M, Dwivedi G, Lavertu M, et al.. Vaccine technologies and platforms for infectious diseases : current progress, challenges, and opportunities. Vaccines 2021; 9(1940): 1–31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8708925</ArticleId><ArticleId IdType="pubmed">34960236</ArticleId></ArticleIdList></Reference><Reference><Citation>Wodi AP, Morelli V. Principles of vaccination. Anim Biotec 2021; 87: 1–8.</Citation></Reference><Reference><Citation>Yadav D, Yadav N, Khurana S. Vaccines: present status and applications. In: Lausanne SA. (ed.) Animals biotechnology. Switzerland: Frontiers media, 2014, pp. 523–542.</Citation></Reference><Reference><Citation>Smith KA. Louis Pasteur, the father of immunology ? Front Immunol 2012; 3: 1–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342039</ArticleId><ArticleId IdType="pubmed">22566949</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetter V, Denizer G, Friedland LR, et al.. Understanding modern-day vaccines : what you need to know. Ann Med 2018; 50(2): 110–120.</Citation><ArticleIdList><ArticleId IdType="pubmed">29172780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulmer JB, Valley U, Rappuoli R. Vaccine manufacturing : challenges and solutions. Perspective 2006; 24(11): 1377–1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">17093488</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-guarde JM, Regla-nava JA, Nieto-torres JL. Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine. PLOS Pathog 2015; 11(10): 1–36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626112</ArticleId><ArticleId IdType="pubmed">26513244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch S, Jasny E, Schmidt KE, et al.. New vaccine technologies to combat outbreak situations. Front Immunol 2018; 9(2): 1–24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156540</ArticleId><ArticleId IdType="pubmed">30283434</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvas A. Vaccination in patients with immunosuppression. Türk Ped Arş 2014; 49: 181–185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4462293</ArticleId><ArticleId IdType="pubmed">26078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Mehl F, Zeichner SL. Vaccine strategies to elicit mucosal immunity. Vaccines 2024; 12(2): 191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10892965</ArticleId><ArticleId IdType="pubmed">38400174</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffman R, Sher A, Seder R. Vaccine adjuvants : putting innate immunity to work. Immunity 2012; 33(4): 492–503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3420356</ArticleId><ArticleId IdType="pubmed">21029960</ArticleId></ArticleIdList></Reference><Reference><Citation>Drucker J. Inactivated vaccines: characteristics and principles of use. La Revue du Practicien 1995; 45(45): 1997–1999.</Citation><ArticleIdList><ArticleId IdType="pubmed">7660003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus R, Querton B, Ramljak IC, et al.. Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine ( VLA2001 ) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK ( COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial. Lancet Infect Dis 2022; 22: 1716–1727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9444237</ArticleId><ArticleId IdType="pubmed">36075233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalzik F, Schreiner D, Jensen C, et al.. mRNA-based vaccines. Vaccines 2021; 9(4): 390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103517</ArticleId><ArticleId IdType="pubmed">33921028</ArticleId></ArticleIdList></Reference><Reference><Citation>Giese M. Introduction to Molecular Vaccinology. Switzerland: Springer, 2016.</Citation></Reference><Reference><Citation>Bill RM. Recombinant protein subunit vaccine synthesis in microbes : a role for yeast ? Recombinant protein subunit vaccines. J Pharm Pharmacol 2014; 1: 319–328.</Citation><ArticleIdList><ArticleId IdType="pubmed">25556638</ArticleId></ArticleIdList></Reference><Reference><Citation>
Andersson C. Production and Delivery of Recombinant Subunit Vaccines, https://www.diva-portal.org/smash/record.jsf?pid=diva2%3A8775&amp;dswid=6386 (2000, accessed 09 September 2024).</Citation></Reference><Reference><Citation>El-taher M, Al-Yaqeen. Therapeutic proteins derived from recombinant DNA technology. Int J Curr Microbiol App Sci 2020; 9(1): 2024–2032.</Citation></Reference><Reference><Citation>Gupta V, Sengupta M, Prakash J, et al.. Production of recombinant pharmaceutical proteins. Basic Appl Asp Biotechnol 2017: 77–101.</Citation></Reference><Reference><Citation>Clancy S, Brown W. Translation : DNA to mRNA to protein. Nat Educ 2018; 1(1): 2–6.</Citation></Reference><Reference><Citation>Volgin DV. Gene expression : analysis and quantitation. Amesterdam, Netherlands: Elsevier, 2014.</Citation></Reference><Reference><Citation>
Dornell J.
RNA polymerase: function and definition, https://www.technologynetworks.com/genomics/articles/rna-polymerase-function-and-definition-346823 (2021, accessed 10 September 2024).</Citation></Reference><Reference><Citation>Stenesh J, Stenesh. Transcription-the synthesis of RNA. Biochemistry 1998: 453–475.</Citation></Reference><Reference><Citation>Hansson M, Nygren P-A, Stahl S. Design and production of recombinant subunit vaccines introduction to vaccinology. Biotechnol Appl Biochem 2000; 32: 95–107.</Citation><ArticleIdList><ArticleId IdType="pubmed">11001870</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC and IDSA. Recombinant subunit vaccines. nJQV3. https://www.cdc.gov/vaccine-safety/about/adjuvants.html (2022, accessed 4 July 2023).</Citation></Reference><Reference><Citation>Wang M, Jiang S, Wang Y. Recent advances in the production of recombinant subunit vaccines in Pichia pastoris. Bioengineered 2016; 7(3): 155–165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927204</ArticleId><ArticleId IdType="pubmed">27246656</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma SK, Mahajan P, Rappuoli R, et al.. New-age vaccine adjuvants, their development, and future perspective. Front Immunol 2023; 2(February): 1–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9998920</ArticleId><ArticleId IdType="pubmed">36911719</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirahmadi S, Zakeri S, Djadid ND, et al.. A review of combination adjuvants for malaria vaccines : a promising approach for vaccine development. Int J Parasitol 2021; 51(9): 699–717.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ura T, Okuda K, Shimada M. Developments in viral vector-based vaccines. Vaccines 2014; 2(3): 624–641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4494222</ArticleId><ArticleId IdType="pubmed">26344749</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng S, Liang H, Chen P, et al.. Viral vector vaccine development and application during the COVID-19 pandemic. Microorganisms 2022; 10(1450): 1–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9317404</ArticleId><ArticleId IdType="pubmed">35889169</ArticleId></ArticleIdList></Reference><Reference><Citation>Travieso T, Li J, Mahesh S. The use of viral vectors in vaccine development. NPJ Vaccines 2022; 75: 1–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9253346</ArticleId><ArticleId IdType="pubmed">35787629</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys IR, Sebastian S. Novel viral vectors in infectious diseases. Immunology 2017; 153: 1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5721250</ArticleId><ArticleId IdType="pubmed">28869761</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov 2021; 20(November): 817–838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386155</ArticleId><ArticleId IdType="pubmed">34433919</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolgin E. The tangled history of mRNA vaccines. Nature 2021; (September): 597: 318–324.</Citation><ArticleIdList><ArticleId IdType="pubmed">34522017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi WY, Li Y Der, Huang HC, et al.. COVID-19 vaccine update : vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J Biomed Sci 2022; 29(1): 1–27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9569411</ArticleId><ArticleId IdType="pubmed">36243868</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka Chopra H, Choudhary OP. mRNA vaccines as an armor to combat the infectious diseases. Travel Med Infect Dis 2023; 52: 102550.</Citation><ArticleIdList><ArticleId IdType="pubmed">36754340</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JW, Lagniton PNP, Liu Y, et al.. mRNA vaccines for COVID-19 : what, why and how. Int J Biol Sci 2021; 17(6): 1446–1460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8071766</ArticleId><ArticleId IdType="pubmed">33907508</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiolet T, Kherabi Y, Macdonald C, et al.. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern : a narrative review. Clin Microbiol Infect 2022; 28(2): 202–221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548286</ArticleId><ArticleId IdType="pubmed">34715347</ArticleId></ArticleIdList></Reference><Reference><Citation>Giese M. Types of recombinant vaccines 9. Cham, Switzerland: Springer International Publishing, 2016.</Citation></Reference><Reference><Citation>FDA. Guidance for industry considerations for plasmid DNA vaccines for infectious disease. Maryland, Silver Spring: U.S Food and Drug Administration, 2007.</Citation></Reference><Reference><Citation>Lu B, Lim JM, Yu B, et al.. The next-generation DNA vaccine platforms and delivery systems : advances, challenges and prospects. Front Immunol 2024; 15: 1–24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10867258</ArticleId><ArticleId IdType="pubmed">38361919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolhassani A, Yazdi SR. DNA immunization as an efficient strategy for vaccination. Avicenna J Med Biotech 2009; 1(2): 71–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3558129</ArticleId><ArticleId IdType="pubmed">23407787</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslow JN, Kwon I, Kudchodkar SB, et al.. DNA vaccines for epidemic preparedness : SARS-CoV-2 and Beyond. Vaccines 2023; 11(1016): 1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10302025</ArticleId><ArticleId IdType="pubmed">37376404</ArticleId></ArticleIdList></Reference><Reference><Citation>Suschak JJ, Williams JA, Schmaljohn CS. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Hum Vaccin Immunother 2017; 13(12): 2837–2848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5718814</ArticleId><ArticleId IdType="pubmed">28604157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>